Clinical Trial

A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain

Study acronym: TRIUMPH-7
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The main purpose of this study is to evaluate the efficacy and safety of retatrutide in relieving chronic low back pain in participants who have obesity or overweight. Participation in the study will last about 80 weeks.
Protocol Amendment History 1 change
notable Trial sites reduced: 46 -> 41 locations 2026-04-18
Trial Details
NCT Number NCT07035093
Lead Sponsor Eli Lilly and Company
Conditions Obesity, Overweight, Chronic Low Back Pain (CLBP)
Enrollment 586 participants
Start Date 2025-05-29
Primary Completion 2027-09 (estimated)
Study Completion 2027-09 (estimated)
Updated on ClinicalTrials.gov 2026-05-20